Potential applications of influenza A virus vectors as tumor vaccines

Reverse genetics techniques have been established for the introduction of specific mutations into the influenza A virus genes. These techniques allowed the generation of influenza virus vectors expressing foreign antigens. Expression of tumor-associated antigens (TAAs) by influenza virus vectors might represent a promising way to induce potent cellular immune responses against cancer cells, leading to tumor regression.